Tokyo Tape
Sign in
← Ain Holdings

Half-year report · Q2

9627.TEDINET S100UY0P
Period2024-05-01 → 2024-10-31
Filed2024-12-13
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥214.9bn2024-05-01 → 2024-10-31Cons.Net sales
Revenue¥399.8bn2023-05-01 → 2024-04-30Cons.Net sales (5-year summary)
Revenue¥193.7bn2023-05-01 → 2023-10-31Cons.Net sales
Operating income¥5.9bn2024-05-01 → 2024-10-31Cons.Operating income
Operating income¥8.7bn2023-05-01 → 2023-10-31Cons.Operating income
Ordinary income¥6.3bn2024-05-01 → 2024-10-31Cons.Ordinary income
Ordinary income¥21.4bn2023-05-01 → 2024-04-30Cons.Ordinary income loss (5-year summary)
Ordinary income¥9.3bn2023-05-01 → 2023-10-31Cons.Ordinary income
Profit before tax¥6.7bn2024-05-01 → 2024-10-31Cons.Income before income taxes
Profit before tax¥9.4bn2023-05-01 → 2023-10-31Cons.Income before income taxes
Net income (owners)¥3.2bn2024-05-01 → 2024-10-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥11.4bn2023-05-01 → 2024-04-30Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥5.3bn2023-05-01 → 2023-10-31Cons.Profit loss attributable to owners of parent
Net income¥3.2bn2024-05-01 → 2024-10-31Cons.Profit loss
Net income¥5.2bn2023-05-01 → 2023-10-31Cons.Profit loss
Total assets¥296.0bnat 2024-10-31Cons.Assets
Total assets¥249.4bnat 2024-04-30Cons.Assets
Total assets¥242.9bnat 2023-10-31Cons.Total assets (5-year summary)
Total liabilities¥159.9bnat 2024-10-31Cons.Liabilities
Total liabilities¥114.0bnat 2024-04-30Cons.Liabilities
Net assets / equity¥136.1bnat 2024-10-31Cons.Net assets
Net assets / equity¥135.4bnat 2024-04-30Cons.Net assets
Net assets / equity¥129.8bnat 2023-10-31Cons.Net assets (5-year summary)
Cash and deposits¥27.2bnat 2024-10-31Cons.Cash and deposits
Cash and deposits¥48.6bnat 2024-04-30Cons.Cash and deposits
Cash & equivalents¥27.2bnat 2024-10-31Cons.Cash and cash equivalents
Cash & equivalents¥48.4bnat 2024-04-30Cons.Cash and cash equivalents
Cash & equivalents¥50.3bnat 2023-10-31Cons.Cash and cash equivalents
Cash & equivalents¥46.2bnat 2023-04-30dCons.Cash and cash equivalents
Operating cash flow¥12.7bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in operating activities
Operating cash flow¥23.0bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥14.1bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in operating activities
Investing cash flow−¥54.0bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in investment activities
Investing cash flow−¥15.7bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥5.8bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in investment activities
Financing cash flow¥20.1bn2024-05-01 → 2024-10-31Cons.Net cash provided by used in financing activities
Financing cash flow−¥5.1bn2023-05-01 → 2024-04-30Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥4.2bn2023-05-01 → 2023-10-31Cons.Net cash provided by used in financing activities
EPS (basic)¥91.752024-05-01 → 2024-10-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥324.642023-05-01 → 2024-04-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥149.662023-05-01 → 2023-10-31Cons.Basic earnings loss per share (5-year summary)
Equity ratio46.0%at 2024-10-31Cons.Equity to asset ratio (5-year summary)
Equity ratio54.3%at 2024-04-30Cons.Equity to asset ratio (5-year summary)
Equity ratio53.4%at 2023-10-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 34
SegmentItemPeriodValue
Otherother segmentsrevenue2024-05-01 → 2024-10-31¥5.6bn
Otherother segmentsrevenue external2024-05-01 → 2024-10-31¥5.5bn
Otherother segmentsrevenue intersegment2024-05-01 → 2024-10-31¥24m
Otherother segmentssegment ordinary income2024-05-01 → 2024-10-31−¥15m
Reconciling Itemsreconcilingrevenue2024-05-01 → 2024-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2024-05-01 → 2024-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2024-05-01 → 2024-10-31−¥5.0bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2024-05-01 → 2024-10-31¥186.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2024-05-01 → 2024-10-31¥186.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2024-05-01 → 2024-10-31¥9.6bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2024-05-01 → 2024-10-31¥22.9bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2024-05-01 → 2024-10-31¥22.9bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2024-05-01 → 2024-10-31¥1.7bn
—segment totalrevenue2024-05-01 → 2024-10-31¥214.9bn
—segment totalrevenue external2024-05-01 → 2024-10-31¥214.9bn
—segment totalrevenue intersegment2024-05-01 → 2024-10-31¥24m
—segment totalsegment ordinary income2024-05-01 → 2024-10-31¥11.3bn
Otherother segmentsrevenue2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue external2023-05-01 → 2023-10-31¥5.7bn
Otherother segmentsrevenue intersegment2023-05-01 → 2023-10-31¥24m
Otherother segmentssegment ordinary income2023-05-01 → 2023-10-31−¥49m
Reconciling Itemsreconcilingrevenue2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingrevenue intersegment2023-05-01 → 2023-10-31−¥24m
Reconciling Itemsreconcilingsegment ordinary income2023-05-01 → 2023-10-31−¥4.4bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentrevenue external2023-05-01 → 2023-10-31¥173.2bn
jpcrp040300-q2r_E04896-000Dispensing Pharmacyreportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥12.5bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentrevenue external2023-05-01 → 2023-10-31¥14.8bn
jpcrp040300-q2r_E04896-000Drug And Cosmetic Storereportable segmentsegment ordinary income2023-05-01 → 2023-10-31¥1.3bn
—segment totalrevenue2023-05-01 → 2023-10-31¥193.8bn
—segment totalrevenue external2023-05-01 → 2023-10-31¥193.7bn
—segment totalrevenue intersegment2023-05-01 → 2023-10-31¥24m
—segment totalsegment ordinary income2023-05-01 → 2023-10-31¥13.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 577
ItemContextValueUnit
Other clPrior1YearInstant6784000000JPY
Other clCurrentQuarterInstant7927000000JPY
Current liabilitiesPrior1YearInstant103232000000JPY
Current liabilitiesCurrentQuarterInstant119661000000JPY
Long term loans payablePrior1YearInstant3227000000JPY
Long term loans payableCurrentQuarterInstant28795000000JPY
Net defined benefit liabilityPrior1YearInstant4662000000JPY
Net defined benefit liabilityCurrentQuarterInstant4918000000JPY
Lease obligations nclPrior1YearInstant38000000JPY
Lease obligations nclCurrentQuarterInstant267000000JPY
Asset retirement obligations nclPrior1YearInstant2001000000JPY
Asset retirement obligations nclCurrentQuarterInstant3984000000JPY
Other nclPrior1YearInstant835000000JPY
Other nclCurrentQuarterInstant2230000000JPY
Noncurrent liabilitiesPrior1YearInstant10765000000JPY
Noncurrent liabilitiesCurrentQuarterInstant40197000000JPY
LiabilitiesPrior1YearInstant113998000000JPY
LiabilitiesCurrentQuarterInstant159859000000JPY
Capital stockPrior1YearInstant21894000000JPY
Capital stockCurrentQuarterInstant21894000000JPY
Capital surplusPrior1YearInstant20131000000JPY
Capital surplusCurrentQuarterInstant20128000000JPY
Retained earningsPrior1YearInstant95257000000JPY
Retained earningsCurrentQuarterInstant95643000000JPY
Treasury stockPrior1YearInstant-2436000000JPY
Treasury stockCurrentQuarterInstant-2219000000JPY
Shareholders equityPrior1YearInstant134847000000JPY
Shareholders equityCurrentQuarterInstant135447000000JPY
Valuation difference on available for sale securitiesPrior1YearInstant234000000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant160000000JPY
Deferred gains or losses on hedgesPrior1YearInstant－JPY
Deferred gains or losses on hedgesCurrentQuarterInstant250000000JPY
Foreign currency translation adjustmentPrior1YearInstant－JPY
Foreign currency translation adjustmentCurrentQuarterInstant-1000000JPY
Remeasurements of defined benefit plansPrior1YearInstant225000000JPY
Remeasurements of defined benefit plansCurrentQuarterInstant188000000JPY
Valuation and translation adjustmentsPrior1YearInstant459000000JPY
Valuation and translation adjustmentsCurrentQuarterInstant599000000JPY
Non controlling interestsPrior1YearInstant104000000JPY
Non controlling interestsCurrentQuarterInstant95000000JPY
Net assetsPrior1YearInstant135411000000JPY
Net assetsCurrentQuarterInstant136142000000JPY
Liabilities and net assetsPrior1YearInstant249409000000JPY
Liabilities and net assetsCurrentQuarterInstant296001000000JPY
Net salesPrior1YTDDuration193727000000JPY
Net salesCurrentYTDDuration214860000000JPY
Cost of salesPrior1YTDDuration165960000000JPY
Cost of salesCurrentYTDDuration184763000000JPY
Gross profitPrior1YTDDuration27767000000JPY
Gross profitCurrentYTDDuration30097000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-04-30pass
balance sheet identityconsolidated 2024-10-31pass
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-04-30pass
statement vs summary · net assetsconsolidated 2024-10-31pass
statement vs summary · net income attributable to parentconsolidated 2023-05-01/2023-10-31pass
statement vs summary · net income attributable to parentconsolidated 2024-05-01/2024-10-31pass
statement vs summary · operating cash flowconsolidated 2023-05-01/2023-10-31pass
statement vs summary · operating cash flowconsolidated 2024-05-01/2024-10-31pass
statement vs summary · revenueconsolidated 2023-05-01/2023-10-31pass
statement vs summary · revenueconsolidated 2024-05-01/2024-10-31pass
statement vs summary · total assetsconsolidated 2024-04-30pass
statement vs summary · total assetsconsolidated 2024-10-31pass